ASML raises 2026 outlook 35%, capacity becomes the limit

On July 15, ASML reported strong second-quarter results and significantly raised its full-year 2026 outlook, signaling powerful underlying demand from chipmakers racing to expand AI infrastructure. Second-quarter net sales came in at 9.3 billion euros with a gross margin of 54%, both above company guidance, driven by stronger sales of services and upgrades to existing machines in the field. Net income for the quarter was 2.9 billion euros, and sales grew from 8.1 billion euros in the first quarter. First-half revenue ran about 17% ahead of the same period last year. The company also repurchased about 1.1 billion euros of its own shares during the quarter.

The larger news was the full-year guidance revision. ASML now expects 2026 total net sales of 43 billion to 45 billion euros, up significantly from the 36 billion to 40 billion euros it had forecast in April. At the midpoint, that represents roughly 35% growth over 2025's actual 32.7 billion euros. For the third quarter, the company guided for sales of 11 billion to 12 billion euros, a midpoint that implies more than 20% growth in a single quarter compared to the 9.3 billion euros just reported. CEO Christophe Fouquet stated in the earnings release that "our order intake remained extremely strong in the first half of the year," explaining that customers are accelerating their capacity plans as investments in artificial intelligence (AI) drive demand for advanced logic and memory chips.

ASML holds a unique market position: it is the only company in the world that builds extreme ultraviolet (EUV) lithography machines, the specialized equipment required to print the most advanced chips. When chipmakers race to expand capacity—as they are doing in response to AI demand—the orders flow directly to ASML. However, this dominance reveals a new constraint: ASML's own manufacturing capacity. The company plans to add 30% to its 2026 low-NA EUV capacity of around 65 systems for 2027, and is investigating another 30% increase for 2028. Its deep ultraviolet (DUV) immersion capacity of around 130 systems is slated for the same treatment. In essence, demand is no longer the five-year variable; ASML's ability to build machines is.

For investors, this supply constraint creates a relatively visible growth path. If the 2027 expansion lands and the 2028 one follows, ASML's sales could approach double today's level before the decade ends. A growing services business—built on every machine in the field—further compounds earnings power. However, valuation presents a significant headwind. After more than doubling over the past year, the stock trades at roughly 40 times the earnings implied by its own 2026 guidance. That multiple already prices in years of good news. ASML's order intake can be lumpy quarter to quarter, and if customers pause to digest capacity they are building, the multiple may compress even as the business grows, leaving little room for error. The analyst's projection assumes earnings compound in the high teens as capacity scales and the multiple settles from about 40 toward something closer to 30 times earnings. Under that scenario, with a starting price of about $1,800 per share, 8% annual compounding would put the stock around $2,650 in five years, while 12% annual compounding would reach about $3,180. A second 30% capacity expansion in 2028 or a faster ramp of ASML's newest generation of machines could push results above that range; a pause in AI infrastructure spending would likely drag it below. The underlying business will likely be dramatically larger in five years, but after a 121% run over the past 12 months, the path from here probably resembles normal compounding rather than a repeat of recent performance.

ASML's second-quarter results and upward guidance revision reveal a company at the epicenter of the AI infrastructure buildout. The 2026 revenue guidance increase—from a midpoint of 38 billion euros to 44 billion euros—represents roughly 35% growth over 2025's 32.7 billion euros, an exceptional rate for a mature industrial manufacturer. The strength comes from customers accelerating capacity plans: CEO Christophe Fouquet explicitly tied this to AI-driven investments in advanced logic and memory chips. First-half revenue was about 17% ahead of the prior-year period, and third-quarter guidance implies more than 20% sequential growth, demonstrating momentum across the board.

Yet the analysis in the article identifies a structural shift: demand is no longer the variable. Instead, ASML's own manufacturing capacity has become the constraint. The company's plans to expand low-NA EUV systems by 30% in 2027 and investigate another 30% for 2028—mirrored by comparable increases in deep ultraviolet (DUV) immersion capacity—signal that supply, not customer appetite, will dictate the pace of growth through the end of the decade. This visibility is unusual for a growth stock and cuts both ways: it makes the path to earnings power relatively clear, but it also means ASML's upside hinges on successfully executing those capacity expansions.

The valuation risk is substantial. At roughly 40 times 2026 guidance earnings, the stock has already priced in multiple years of strong performance. The article acknowledges that AI-linked stocks generally carry this risk, but the impact is sharper when the starting multiple is so high. A pause in customer spending or weaker-than-expected orders could compress the multiple even as the underlying business grows, limiting total returns. The analyst's 8–12% annual return estimate assumes both that earnings compound in the high teens and that the valuation multiple normalizes downward to around 30 times earnings—a scenario that requires successful execution and a moderate revaluation.